approval
saveLAZCLUZE (LAZERTINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalAug 19, 2024
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalAug 2, 2024
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalJul 30, 2024
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalSep 11, 2024
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalSep 19, 2024
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalJul 9, 2024
comments(0)
5-min edit window · permanent after that